Consensus Vigil Neuroscience, Inc.

Equities

VIGL

US92673K1088

Delayed Nasdaq Other stock markets 09:53:54 2024-05-13 EDT			5-day change	1st Jan Change
3.24 ^USD	+1.89%		+12.11%	-4.14%

05-07	Vigil Neuroscience, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
04-17	Vigil Neuroscience, Inc. Presents Key Findings from Illuminate & Ignite Studies in ALSP At the 2024 American Academy of Neurology Annual Meeting	CI

Evolution of the average Target Price on Vigil Neuroscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

019852a5f.SJbOqhDhoko0kOxe09aMfoS8egT9IBcY_3gDsxwZ3hM.cfWU2yPX7h9R3IssnpPODuPsDEKiYU5uuBtcgXRquEMw94yeWNn9IUykpQ~c809896fac66f425a7e719c723d159d8

Analyst Recommendations on Vigil Neuroscience, Inc.

Wedbush Trims Vigil Neuroscience Price Target to $22 From $23, Maintains Outperform Rating	03-26	MT
Morgan Stanley Downgrades Vigil Neuroscience to Underweight From Equalweight, Cuts Price Target to $4 From $13	12-19	MT
JMP Securities Starts Vigil Neuroscience With Market Outperform Rating, Price Target is $23	23-10-18	MT
Mizuho Adjusts Price Target on Vigil Neuroscience to $13 From $15, Keeps Buy Rating	23-08-10	MT
Mizuho Initiates Vigil Neuroscience at Buy With $15 Price Target	23-03-31	MT
Morgan Stanley Adjusts Vigil Neuroscience Price Target to $13 From $12, Maintains Equal Weight Rating	23-03-27	MT
Morgan Stanley Adjusts Price Target on Vigil Neuroscience to $12 From $11, Maintains Equalweight Rating	22-11-14	MT
Guggenheim Trims Price Target on Vigil Neuroscience to $19 From $22, Maintains Buy Rating	22-11-11	MT
Wedbush Trims Vigil Neuroscience's Price Target to $23 From $24 on Higher Share Count, Keeps Outperform Rating	22-11-11	MT
Wedbush Starts Vigil Neuroscience at Outperform With $19 Price Target	22-09-16	MT
HC Wainwright Starts Vigil Neuroscience at Buy With $24 Price Target	22-08-29	MT
Morgan Stanley Lowers Vigil Neuroscience's Price Target to $11 From $17, Maintains Equalweight Rating	22-05-17	MT
Morgan Stanley Starts Vigil Neuroscience at Equalweight With $17 Price Target	22-02-01	MT
Guggenheim Starts Vigil Neuroscience at Buy With $23 Price Target	22-02-01	MT
Stifel Starts Vigil Neuroscience at Buy With $24 Price Target	22-02-01	MT
Jefferies Starts Vigil Neuroscience at Buy With $20 Price Target	22-02-01	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

3.18 USD

Average target price

18.57 USD

Spread / Average Target

+484.01%

High Price Target

24 USD

Spread / Highest target

+654.72%

Low Price Target

11 USD

Spread / Lowest Target

+245.91%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Vigil Neuroscience, Inc.

Wedbush
Morgan Stanley
JMP Securities
Mizuho Securities
Guggenheim
HC Wainwright
Jefferies & Co.
Stifel Nicolaus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar